2-(3-chlorophenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one

ID: ALA1091765

PubChem CID: 6187657

Max Phase: Preclinical

Molecular Formula: C15H9ClN2O2

Molecular Weight: 284.70

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1OC(c2cccc(Cl)c2)=N/C1=C\c1cccnc1

Standard InChI:  InChI=1S/C15H9ClN2O2/c16-12-5-1-4-11(8-12)14-18-13(15(19)20-14)7-10-3-2-6-17-9-10/h1-9H/b13-7-

Standard InChI Key:  JECOGJJTAAXRQA-QPEQYQDCSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
   13.6792  -22.2960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6446  -23.1227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3421  -23.5641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0747  -23.1801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1054  -22.3502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4072  -21.9124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4381  -21.0880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1676  -20.7026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8393  -21.1881    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5050  -20.6960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2440  -19.9160    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4191  -19.9212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9313  -19.2558    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.3262  -20.7014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7323  -21.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5565  -21.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9756  -20.7162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5645  -19.9960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7417  -19.9925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9628  -22.1458    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  5  6  2  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
  6  1  1  0
 12 13  2  0
  1  2  2  0
  6  7  1  0
 14 15  2  0
  3  4  2  0
 15 16  1  0
  7  8  2  0
 16 17  2  0
  8  9  1  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 10 14  1  0
  4  5  1  0
 16 20  1  0
M  END

Associated Targets(Human)

DAPK3 Tchem Death-associated protein kinase 3 (2108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 284.70Molecular Weight (Monoisotopic): 284.0353AlogP: 3.08#Rotatable Bonds: 2
Polar Surface Area: 51.55Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.68CX LogP: 3.23CX LogD: 3.23
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.63Np Likeness Score: -1.69

References

1. Okamoto M, Takayama K, Shimizu T, Muroya A, Furuya T..  (2010)  Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening.,  18  (7): [PMID:20206532] [10.1016/j.bmc.2010.02.018]

Source